# Current Summary of Evidence

 This document summarizes the current evidence status of adjunctive perioperative interventions that supplement standard surgical care across the pre-operative, intra-operative, and post-operative phases‚Äîbased on the strength, consistency, and clinical relevance of available human data.

Do not use this document as a primary source. Validate all information with the original sources before using it. Any use should be reviewed and directed by your medical care provider and your surgical team.

## üü¢ Strong Evidence for Use

### Zinc

Evidence details: [Zinc Supplementation for Post-Surgical Wound Healing](supplements/zinc-supplementation-post-surgical-wound-healing.md)

- Treat/avoid zinc deficiency to support wound healing and reduce wound complications. Across older RCT signals plus modern synthesis, benefit is most consistent when baseline zinc is low (deficiency/suboptimal status).
- Short-term perioperative zinc (typ. ~30‚Äì50 mg elemental/day for a few weeks) may improve healing-related outcomes, especially in high-demand states (large wounds/burns/chronic wounds) and may reduce infection/inflammation in some surgical settings.
- Evidence base includes a recent meta-analysis of small RCTs suggesting improved healing endpoints overall, but trials are heterogeneous and often small.
- In well-nourished patients with uncomplicated acute surgical wounds, speed-of-closure benefits are inconsistent; some studies suggest infection/colonization improvements more than faster closure.
- **‚ö†Ô∏èRisks/cautions:** Chronic/high dosing (commonly ‚â•50 mg/day for many weeks) can cause copper deficiency (anemia/neutropenia); GI upset is possible. Separate dosing from quinolones/tetracyclines to avoid absorption issues.

### Methylfolate + Methylcobalamin

Evidence details: [Methylfolate and Methylcobalamin in Surgical Recovery](supplements/methylfolate-methylcobalamin-surgical-recovery.md)

- Preventing/treating deficiency in high-risk groups (e.g., post-bariatric surgery, restrictive diets) is strongly evidence-based as standard care (prevention of anemia/neuropathy), though not proven as a ‚Äúrecovery accelerator.‚Äù
- Perioperative B12 adequacy is clinically important when nitrous oxide (N‚ÇÇO) is used, because N‚ÇÇO can inactivate B12 and precipitate neurologic injury in deficient patients (benefit is harm prevention, not faster healing).
- Nerve recovery: mixed‚Äîone non-randomized positive signal in a specific neuro-rehab combination, but a double-blind RCT in knee arthroplasty showed no benefit for incision numbness with methylcobalamin.
- Folate and chronic ulcers: some supportive controlled/observational data in diabetic/venous ulcers, but not directly generalizable to acute surgical incisions.
- No RCTs demonstrating that methylfolate or methylcobalamin improves general surgical wound healing or speeds overall recovery in otherwise replete patients.
- **‚ö†Ô∏èRisks/cautions:** Generally low; key practical risk is masking B12 deficiency with high folate (less relevant if B12 status is ensured). Main perioperative concern is unrecognized B12 deficiency + N‚ÇÇO exposure (harm from deficiency, not the supplement).

### Caffeine / Coffee (post-op)

Evidence details: [Caffeine Use After Surgery and Recovery Outcomes](diet-and-lifestyle/caffeine-use-after-surgery-recovery-outcomes.md)

- Postoperative coffee to speed GI recovery after abdominal surgery (multiple RCTs/meta-analyses): earlier bowel function, reduced ileus risk, and shorter LOS in several populations (colorectal/gynecologic/C-section).
- Analgesic adjuvant: adding caffeine to standard analgesics modestly improves pain relief (Cochrane-level evidence).
- Withdrawal headache prevention in habitual users: perioperative caffeine (including IV caffeine in PACU) reduces headache incidence in RCT data.
- Reduced facial swelling: limited to a single dental implant RCT using an acetaminophen+caffeine combination vs acetaminophen+codeine.
- Anesthesia emergence / alertness: suggestive but not definitive; confounded observational data.
- No direct evidence facial plastic surgeries for improved wound healing or reduced bruising.
- **‚ö†Ô∏èRisks/cautions:** No consistent clinical signal of harm at moderate intake in studies, but plausible perioperative issues include transient BP/HR increases, dehydration if fluid intake is poor, and lab (non-clinical) evidence suggesting impaired epithelialization at high exposures. Practical implication: moderation + hydration, and defer to surgeon-specific restrictions in high-bleeding-risk facial cases.

## üü¢ Moderate Evidence for Use

### Bromelain for Oral/Maxillofacial and Bone-Involving Facial Surgery

Evidence details: [Bromelain for Oral, Maxillofacial, and Bone-Involving Facial Surgery](supplements/bromelain-oral-maxillofacial-bone-surgery.md)

- Postoperative pain reduction after oral/maxillofacial procedures has moderate-to-strong support: meta-analysis of 6 RCTs in third molar surgery showed significant pain reduction at 24 hours and 7 days (SMD -0.49 to -0.52), comparable to NSAIDs.
- Bruise/ecchymosis resolution is procedure-dependent: significant benefit in rhinoplasty with osteotomies (RCT, p=0.012 by day 7); no significant effect in blepharoplasty (p=0.67). Efficacy correlates with fibrin-rich hematoma volume from bone trauma.
- Swelling/edema outcomes are mixed across meta-analyses; some show benefit at 2‚Äì3 days and 7 days post-op, while others do not. Variation may reflect measurement techniques and procedure type.
- Trismus outcomes are mixed/inconclusive: some reviews suggest improvement in mouth opening, while others find no significant effect by day 7; depends on included trials and measurement methods.
- **‚ö†Ô∏èRisks/cautions:** Biologic anticoagulant/antiplatelet effects (ex vivo PT prolongation up to 47%; platelet aggregation inhibition ~19%) raise a plausible hematoma/bleeding risk, especially with anticoagulants/antiplatelets or in bleeding-prone patients. Practical implication: many periop protocols conservatively recommend stopping 10‚Äì14 days pre-op; any "pre-loading" strategy should be surgeon-directed.

### Collagen peptides + Vitamin C

Evidence details: [Collagen Peptides + Vitamin C for Post-FFS Healing and Bruising](supplements/collagen-peptides-vitamin-c-post-ffs-healing-bruising.md)

- Collagen peptides: RCT evidence in high-demand wound contexts (e.g., burns; pressure ulcers) suggests faster wound closure/improved wound scores.
- Vitamin C: RCT evidence in oral surgery indicates reduced early swelling/pain and improved short-term wound parameters; correcting insufficiency is biologically and clinically important.
- Direct evidence for reducing bruising in elective surgery is limited; the rationale is strongest for patients with suboptimal intake or higher tissue-repair demands.
- No direct trials in FFS demonstrating improved cosmetic outcomes, scar quality, or complication reduction.
- **‚ö†Ô∏èRisks/cautions:** Generally low risk. Allergy/source issues (marine collagen in fish-allergic individuals). High-dose vitamin C can cause GI upset and may increase kidney stone risk in predisposed individuals. No clear bleeding-risk signal at typical doses.

## üü° Limited or Mixed Evidence for Use

### Astaxanthin (pre-op use)

Evidence details: [Astaxanthin Use Before Surgery - Evidence and Considerations](supplements/astaxanthin-use-before-surgery-evidence-considerations.md)

- No strong or moderate perioperative RCT evidence showing improved surgical outcomes.
- Limited human perioperative evidence (small, non-randomized cataract surgery studies) suggests reduced local oxidative stress and lower early post-op inflammation.
- Strong preclinical (animal) evidence for protection in ischemia‚Äìreperfusion injury models, but translation to routine elective surgery remains uncertain.
- No robust clinical evidence supporting routine pre-op astaxanthin to improve healing, pain, swelling, or complication rates across surgeries.
- **‚ö†Ô∏èRisks/cautions:** Bleeding/anticoagulant concern: animal data show prolonged clotting times and reduced platelet aggregation; plus a warfarin interaction case report with extreme INR elevation and bruising. Practical implication: avoid perioperatively unless surgeon/anesthesia explicitly agree, and avoid particularly with anticoagulants/antiplatelets.

### BPC-157 for Improving Surgical Outcomes and Recovery

Evidence details: [BPC-157 for Improving Surgical Outcomes and Recovery](supplements/bpc-157-improving-surgical-outcomes-recovery.md)

- Rationale/preclinical:** Strong and consistent animal/in vitro signals across multiple tissue types (skin incisions/burns, tendon/ligament, muscle-to-bone repair, fractures/bone defects, GI anastomosis and fistulas), including improved collagen organization, angiogenesis, and tensile/biomechanical strength.
- Human evidence is early/low quality for perioperative use:** Human data consist mainly of a Phase I safety study (short-term oral exposure) and small pilot/observational reports in non-surgical or not-clearly-perioperative contexts (e.g., knee pain injections; bladder pain/interstitial cystitis intravesical injection). These do **not** establish that BPC-157 improves routine surgical wound healing, swelling/bruising, infection rates, scar quality, or recovery time in typical surgical patients.
- No direct trials in facial plastic surgery/FFS (or in elective surgical recovery broadly) demonstrating clinically meaningful benefit; randomized perioperative trials are limited/ongoing.
- Practical interpretation: At present, BPC-157 remains an experimental candidate with impressive preclinical breadth but insufficient human perioperative efficacy evidence to recommend routine use as a ‚Äúrecovery accelerator.‚Äù
- **‚ö†Ô∏èRisks/cautions:** Regulatory/quality risk is central (not FDA-approved; access often via unregulated ‚Äúresearch‚Äù supply with contamination/mislabelling risk; compounding restrictions). Safety data in humans are limited by small sample sizes and short follow-up. Theoretical concerns include pro-angiogenic effects (uncertain implications in patients with active/occult malignancy) and unknown interactions with perioperative medications. Use (if considered at all) should be surgeon/anesthesia-directed and avoided when product quality and medical oversight cannot be assured.

## üü† No Evidence for Use

### Progesterone (post-FFS ‚Äúsodium/sleep/healing‚Äù)

Evidence details: [Progesterone After Facial Feminization Surgery - Sodium and Sleep Effects](hormones/progesterone-after-facial-feminization-surgery-sodium-sleep-effects.md)

- No controlled human surgical trials demonstrating progesterone improves wound healing, swelling, bruising, or overall recovery after surgery/FFS.
- Sleep improvement: moderate evidence in perimenopausal cis women (and meta-analytic support for some sleep parameters) that oral micronized progesterone can improve perceived sleep‚Äîthis is not surgical evidence and may not generalize.
- Transfeminine-specific sleep data are limited and not clearly positive (small prospective controlled study showed no significant sleep benefit at 100 mg).
- Mechanistic/animal wound-healing rationale exists but is not validated in human surgical trials.
- Sodium/fluid effects are plausible (antimineralocorticoid activity) but unproven postoperatively.
- Large trauma trials (TBI) show no recovery benefit in a major-injury context.
- **‚ö†Ô∏èRisks/cautions:** IV progesterone in TBI trials increased thrombophlebitis (likely formulation-related), reminding that progesterone is not risk-free in acute care contexts. Any hormone use post-op requires attention to VTE risk in the perioperative period (context-dependent). Sedation/dizziness can be clinically relevant.

## üî¥ Evidence of Harm with Use

### Low-carbohydrate / Ketogenic diets (peri- and post-op)

Evidence details: [Low-Carbohydrate Diets After Surgery - Evidence and ERAS Guidelines](diet-and-lifestyle/low-carbohydrate-diets-after-surgery-evidence-eras-guidelines.md)

- None for surgical recovery; evidence-based periop nutrition practices generally go the opposite direction (ERAS carbohydrate strategies).
- Keto can reduce chronic inflammatory markers in non-surgical populations, but this is not evidence of benefit in acute surgical healing.
- No clinical trials showing keto/very-low-carb improves postoperative bruising, swelling, wound healing, or recovery in surgery (including FFS).
- **‚ö†Ô∏èRisks/cautions:** Evidence of perioperative risk signals: ketosis associated with metabolic acidosis in fasted surgical patients; pediatric keto anesthesia experience includes clinically significant acidosis requiring treatment; potential hypoglycemia/electrolyte challenges; and observational evidence of platelet function changes/bruising in some keto patients. Clinical implication: avoid intentional perioperative ketosis unless medically indicated and managed by the surgical/anesthesia team; follow ERAS-style nutrition when appropriate.

### High-dose Vitamin D (for bone healing)

Evidence details: [High-Dose Vitamin D and Post-Surgical Bone Healing](supplements/high-dose-vitamin-d-post-surgical-bone-healing.md)

- Correct vitamin D deficiency to support normal bone health (standard of care rationale), but this is distinct from ‚Äúhigh-dose for faster healing.‚Äù
- Limited: one small lumbar fusion RCT suggests possible faster time-to-fusion and better early pain/function with modest dosing (800 IU/day) plus calcium, but not clearly improved final fusion rates.
- Observational associations link low vitamin D with poorer orthopedic outcomes, but intervention trials for ‚Äúboosting healing‚Äù are largely negative.
- High-dose or bolus vitamin D does not reliably improve fracture union/healing in RCTs and systematic reviews; no evidence in craniofacial/FFS osteotomies.
- **‚ö†Ô∏èRisks/cautions:** High-dose/bolus regimens can be harmful: RCT signal of worsened bone microarchitecture in one distal radius fracture trial; known toxicity risk (hypercalcemia) with excessive dosing; large intermittent doses linked to increased falls/fractures in other populations. Clinical implication: aim for sufficiency, avoid mega-dosing unless medically indicated and monitored.
